智通财经网·2025-10-30 09:02Core Viewpoint - UBS reported that Kanglong Chemical (03759) achieved a 13.4% year-on-year revenue increase in Q3, reaching 3.65 billion RMB, which is in line with market and UBS forecasts of 3.6 billion and 3.7 billion RMB respectively [1] - Net profit rose by 42.5% year-on-year to 440 million RMB, which fell short of market and UBS predictions of 467 million and 506 million RMB respectively [1] - The company saw a 13% year-on-year growth in new orders for the first three quarters, accelerating from approximately 10% growth in the first half of the year [1] - UBS slightly raised its revenue and net profit forecasts for the company from 2023 to 2027, increasing the target price for the H-shares from 31 HKD to 32.9 HKD while maintaining a "Buy" rating [1] Financial Performance - Q3 revenue increased by 13.4% to 3.65 billion RMB [1] - Net profit increased by 42.5% to 440 million RMB [1] - New orders grew by 13% year-on-year in the first three quarters [1] Forecast Adjustments - UBS adjusted revenue and net profit forecasts for the company for the years 2023 to 2027 [1] - Target price for H-shares raised from 31 HKD to 32.9 HKD [1] - "Buy" rating maintained by UBS [1]